148 related articles for article (PubMed ID: 3493451)
1. Positron emission tomography and histopathology in Pick's disease.
Kamo H; McGeer PL; Harrop R; McGeer EG; Calne DB; Martin WR; Pate BD
Neurology; 1987 Mar; 37(3):439-45. PubMed ID: 3493451
[TBL] [Abstract][Full Text] [Related]
2. Glial fibrillary acidic protein is a major target of glycoxidative and lipoxidative damage in Pick's disease.
Muntané G; Dalfó E; Martínez A; Rey MJ; Avila J; Pérez M; Portero M; Pamplona R; Ayala V; Ferrer I
J Neurochem; 2006 Oct; 99(1):177-85. PubMed ID: 16987245
[TBL] [Abstract][Full Text] [Related]
3. Functional imaging, the frontal lobes, and dementia.
Friedland RP; Koss E; Lerner A; Hedera P; Ellis W; Dronkers N; Ober BA; Jagust WJ
Dementia; 1993; 4(3-4):192-203. PubMed ID: 8401792
[TBL] [Abstract][Full Text] [Related]
4. [Disorders of glucose metabolism in Pick's disease].
Szelies B; Karenberg A
Fortschr Neurol Psychiatr; 1986 Dec; 54(12):393-7. PubMed ID: 3493192
[TBL] [Abstract][Full Text] [Related]
5. Positron emission tomographic study in Alzheimer's disease and Pick's disease.
Salmon E; Franck G
Arch Gerontol Geriatr Suppl; 1989; 1():241-7. PubMed ID: 2787995
[TBL] [Abstract][Full Text] [Related]
6. [Cerebral glucose metabolism in dementia (PET-FDG study)].
Hatazawa J; Itoh M; Matsuzawa T
Rinsho Hoshasen; 1989 Oct; 34(11):1343-8. PubMed ID: 2601096
[TBL] [Abstract][Full Text] [Related]
7. [F-18 FDG PET in dementia].
Ichiya Y
Rinsho Hoshasen; 1989 Oct; 34(11):1337-41. PubMed ID: 2601095
[TBL] [Abstract][Full Text] [Related]
8. Comparison of PET, MRI, and CT with pathology in a proven case of Alzheimer's disease.
McGeer PL; Kamo H; Harrop R; McGeer EG; Martin WR; Pate BD; Li DK
Neurology; 1986 Dec; 36(12):1569-74. PubMed ID: 3491344
[TBL] [Abstract][Full Text] [Related]
9. Positron emission tomography in dementia.
Friedland RP
Semin Neurol; 1989 Dec; 9(4):338-44. PubMed ID: 2701778
[No Abstract] [Full Text] [Related]
10. 18F-2-deoxy-2-fluoro-D-glucose as a tracer in the positron emission tomographic study of senile dementia.
Farkas T; Ferris SH; Wolf AP; De Leon MJ; Christman DR; Reisberg B; Alavi A; Fowler JS; George AE; Reivich M
Am J Psychiatry; 1982 Mar; 139(3):352-3. PubMed ID: 6977276
[No Abstract] [Full Text] [Related]
11. Lobar atrophy without Pick bodies.
Hulette CM; Crain BJ
Clin Neuropathol; 1992; 11(3):151-6. PubMed ID: 1611728
[TBL] [Abstract][Full Text] [Related]
12. The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia.
Benson DF; Kuhl DE; Hawkins RA; Phelps ME; Cummings JL; Tsai SY
Arch Neurol; 1983 Nov; 40(12):711-4. PubMed ID: 6605139
[TBL] [Abstract][Full Text] [Related]
13. The spectrum of imaging and neuropsychological findings in Pick's disease.
Knopman DS; Christensen KJ; Schut LJ; Harbaugh RE; Reeder T; Ngo T; Frey W
Neurology; 1989 Mar; 39(3):362-8. PubMed ID: 2927644
[TBL] [Abstract][Full Text] [Related]
14. A post-mortem comparison of the cortical cholinergic system in Alzheimer's disease and Pick's disease.
Wood PL; Etienne P; Lal S; Nair NP; Finlayson MH; Gauthier S; Palo J; Haltia M; Paetau A; Bird ED
J Neurol Sci; 1983 Dec; 62(1-3):211-7. PubMed ID: 6142096
[TBL] [Abstract][Full Text] [Related]
15. Regional cerebral glucose metabolism in aging and senile dementia as determined by 18F-deoxyglucose and positron emission tomography.
Alavi A; Reivich M; Ferris S; Christman D; Fowler J; MacGregor R; Farkas T; Greenberg J; Dann R; Wolf A
Exp Brain Res; 1982; Suppl 5():187-95. PubMed ID: 6983979
[No Abstract] [Full Text] [Related]
16. Cortical glucose utilization patterns in primary degenerative dementias of the anterior and posterior type.
Chase TN; Burrows GH; Mohr E
Arch Gerontol Geriatr; 1987 Sep; 6(3):289-97. PubMed ID: 2446576
[TBL] [Abstract][Full Text] [Related]
17. Patterns of cerebral glucose utilization in depression, multiple infarct dementia, and Alzheimer's disease.
Kuhl DE; Metter EJ; Riege WH
Res Publ Assoc Res Nerv Ment Dis; 1985; 63():211-26. PubMed ID: 4023401
[TBL] [Abstract][Full Text] [Related]
18. Positron emission tomography findings in dementia disorders: contributions to differential diagnosis and objectivizing of therapeutic effects.
Heiss WD; Herholz K; Pawlik G; Hebold I; Klinkhammer P; Szelies B
Keio J Med; 1989 Jun; 38(2):111-35. PubMed ID: 2674513
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of cerebral glucose utilization in dementia.
Matsuzawa T; Matsui H; Meguro K; Ueda M; Yamada K; Yamaguchi T; Itoh M; Hatazawa J; Kinomura S
Sci Rep Res Inst Tohoku Univ Med; 1990 Dec; 37(1-4):11-21. PubMed ID: 2103655
[TBL] [Abstract][Full Text] [Related]
20. Positron emission tomography in the differential diagnosis of organic dementias.
Heiss WD; Kessler J; Szelies B; Grond M; Fink G; Herholz K
J Neural Transm Suppl; 1991; 33():13-9. PubMed ID: 1753242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
